{"database": "lobbying", "table": "lobbying_activities", "rows": [[2461967, "77b2d29e-5aed-4935-bb8c-c937bec7c79e", "Q2", "RICCHETTI INCORPORATED", 62778, "EISAI, INC.", 2020, "second_quarter", "MMM", "issues related to coverage of obesity drugs under Federal health care programs\npolicies affecting protected classes of drugs under Federal health care programs\nissues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs\nissues related to the design of the Medicare drug benefit, drug pricing, and drug transparency", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-07-07T15:32:58.730000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2461967"], "units": {}, "query_ms": 35.91683600097895, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}